Screening History and 7-Year Survival in 32,099 Colorectal Cancer Patients: A Population-Based Cohort Study

References

• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. doi:10.5114/pg.2018.81072
   PubMed Web of Science ®Google Scholar
• Taiwan cancer registry. Incidence and mortality rates for top 10 cancers in Taiwan; 2019. Available from: https://twcr.tw/wp-content/uploads/2022/02/Top-10-cancers-in-Taiwan-2019.pdf. Accessed September 27, 2023.
   Google Scholar
• Chiu HM, Chang LC, Hsu WF, et al. Non-invasive screening for colorectal cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):953–965. doi:10.1016/j.bpg.2015.09.015
   PubMed Web of Science ®Google Scholar
• Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol Hepatol. 2022;7(1):60–68. doi:10.1016/S2468-1253(21)00368-X
   PubMed Web of Science ®Google Scholar
• Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467. doi:10.1136/bmj.g2467
   PubMed Web of Science ®Google Scholar
• Hamza S, Cottet V, Touillon N, et al. Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer. Dig Liver Dis. 2014;46(12):1121–1125. doi:10.1016/j.dld.2014.08.041
   PubMedGoogle Scholar
• Law CC, Wong CHN, Chong PSK, et al. Effectiveness of population-based colorectal cancer screening programme in down-staging. Cancer Epidemiol. 2022;79:102184. doi:10.1016/j.canep.2022.102184
   PubMed Web of Science ®Google Scholar
• Larsen MB, Njor S, Ingeholm P, et al. Effectiveness of colorectal cancer screening in detecting earlier-stage disease-a nationwide cohort study in Denmark. Gastroenterology. 2018;155(1):99–106. doi:10.1053/j.gastro.2018.03.062
   PubMed Web of Science ®Google Scholar
• McClements PL, Madurasinghe V, Thomson CS, et al. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends. Cancer Epidemiol. 2012;36(4):e232–242. doi:10.1016/j.canep.2012.02.006
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–1425. doi:10.1093/jnci/djh275
   PubMed Web of Science ®Google Scholar
• Brenner H, Jansen L, Ulrich A, et al. Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget. 2016;7(28):44695–44704. doi:10.18632/oncotarget.9412
   PubMedGoogle Scholar
• Cienfuegos JA, Baixauli J, Martinez Ortega P, et al. Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers. Rev Esp Enferm Dig. 2018;110(11):684–690. doi:10.17235/reed.2018.5509/2018
   PubMed Web of Science ®Google Scholar
• Gill MD, Bramble MG, Hull MA, et al. Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers. Br J Cancer. 2014;111(11):2076–2081. doi:10.1038/bjc.2014.498
   PubMed Web of Science ®Google Scholar
• Luu XQ, Lee K, Jun JK, et al. Effect of colorectal cancer screening on long-term survival of colorectal cancer patients: results of the Korea national cancer screening program. Int J Cancer. 2022;150(12):1958–1967. doi:10.1002/ijc.33953
   PubMed Web of Science ®Google Scholar
• Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer Am Cancer Soc. 2015;121(18):3221–3229.
   Google Scholar
• Chou CK, Chen SL, Yen AM, et al. Outreach and inreach organized service screening programs for colorectal cancer. PLoS One. 2016;11(5):e0155276. doi:10.1371/journal.pone.0155276
   PubMed Web of Science ®Google Scholar
• Chen LS, Liao CS, Chang SH, et al. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (kcis 16). J Med Screen. 2007;14(4):191–199. doi:10.1258/096914107782912022
   PubMed Web of Science ®Google Scholar
• Chiang CJ, Wang YW, Lee WC. Taiwan’s nationwide cancer registry system of 40 years: past, present, and future. J Formos Med Assoc. 2019;118(5):856–858. doi:10.1016/j.jfma.2019.01.012
   PubMed Web of Science ®Google Scholar
• Chiang CJ, You SL, Chen CJ, et al. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol. 2015;45(3):291–296. doi:10.1093/jjco/hyu211
   PubMed Web of Science ®Google Scholar
• Liu CYH, Chuang YT, Chen YL, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manage. 2006;4(1):1–22.
   Google Scholar
• Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168(1):98–104. doi:10.1093/aje/kwn120
   PubMed Web of Science ®Google Scholar
• Chan HC, Huang CC, Huang CC, et al. Predicting colon cancer-specific survival for the asian population using national cancer registry data from Taiwan. Ann Surg Oncol. 2022;29(2):853–863. doi:10.1245/s10434-021-10646-2
   PubMed Web of Science ®Google Scholar
• Chan YM, MacKay C, Ritchie DT, et al. Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study. Surgeon. 2021;19(1):20–26. doi:10.1016/j.surge.2020.02.004
   PubMed Web of Science ®Google Scholar
• Hackl C, Neumann P, Gerken M, et al. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810. doi:10.1186/1471-2407-14-810
   PubMed Web of Science ®Google Scholar
• Pan Z, Peng J, Lin J, et al. Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection? Cancer Commun. 2018;38(1):29. doi:10.1186/s40880-018-0298-8
   PubMed Web of Science ®Google Scholar
• Hee YJ, Bang CS, Baik GH, et al. Association between ischemic heart disease and colorectal neoplasm: a systematic review and meta-analysis. Springerplus. 2016;5(1):1664. doi:10.1186/s40064-016-3349-0
   PubMedGoogle Scholar
• Jeong S, Lee G, Choi S, et al. Estimating risk of cardiovascular disease among long-term colorectal cancer survivors: a nationwide cohort study. Front Cardiovasc Med. 2021;8:721107. doi:10.3389/fcvm.2021.721107
   PubMed Web of Science ®Google Scholar
• Shida H, Ban K, Matsumoto M, et al. Asymptomatic colorectal cancer detected by screening. Dis Colon Rectum. 1996;39(10):1130–1135. doi:10.1007/BF02081414
   PubMed Web of Science ®Google Scholar
• Lee YC, Fann JC, Chiang TH, et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin Gastroenterol Hepatol. 2019;17(7):1332–1340 e1333. doi:10.1016/j.cgh.2018.10.041
   PubMed Web of Science ®Google Scholar
• Jen HH, Hsu CY, Chen SL, et al. Rolling-out screening volume affecting compliance rate and waiting time of fit-based colonoscopy. J Clin Gastroenterol. 2018;52(9):821–827. doi:10.1097/MCG.0000000000000955
   PubMed Web of Science ®Google Scholar
• Wang YW, Chen HH, Wu MS, et al. Current status and future challenge of population-based organized colorectal cancer screening: lesson from the first decade of Taiwanese program. J Formos Med Assoc. 2018;117(5):358–364. doi:10.1016/j.jfma.2017.09.010
   PubMed Web of Science ®Google Scholar
• Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci. 2009;54(4):906–909. doi:10.1007/s10620-008-0407-7
   PubMed Web of Science ®Google Scholar
• Lee KW, Park SK, Yang HJ, et al. Microsatellite instability status of interval colorectal cancers in a Korean population. Gut Liver. 2016;10(5):781–785. doi:10.5009/gnl15376
   PubMed Web of Science ®Google Scholar
• Rutter MD, Beintaris I, Valori R, et al. World endoscopy organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology. 2018;155(3):909–925 e903. doi:10.1053/j.gastro.2018.05.038
   PubMed Web of Science ®Google Scholar
• Jen HH. Consolidated Coxian Phase-Type-Based Stochastic Model for Evaluation of Effectiveness of Population-Based Screening [Unpublished doctoral dissertation]: National Taiwan University; 2019.
   Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371(2):187–188. doi:10.1056/NEJMc1405215
   PubMedGoogle Scholar
• Sturzlinger H, Conrads-Frank A, Eisenmann A, et al. Stool DNA testing for early detection of colorectal cancer: systematic review using the hta core model((r)) for rapid relative effectiveness assessment. Ger Med Sci. 2023;21:Doc06. doi:10.3205/000320
   PubMedGoogle Scholar
• Chang PY, Chen CC, Chiang JM, et al. A simple and highly specific massarray-based stool DNA assay to prioritize follow-up decisions in fecal immunochemical test-positive individuals. Cancers. 2019;11(3). doi:10.3390/cancers11030423
   Web of Science ®Google Scholar
• Collins JF, Lieberman DA, Durbin TE, et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142(2):81–85. doi:10.7326/0003-4819-142-2-200501180-00006
   PubMed Web of Science ®Google Scholar
• Force US, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: us preventive services task force recommendation statement. JAMA. 2021;325(19):1965–1977. doi:10.1001/jama.2021.6238
   PubMed Web of Science ®Google Scholar
• Tepus M, Yau TO. Non-invasive colorectal cancer screening: an overview. Gastrointest Tumors. 2020;7(3):62–73. doi:10.1159/000507701
   PubMed Web of Science ®Google Scholar
• Anand S, Liang PS. A practical overview of the stool DNA test for colorectal cancer screening. Clin Transl Gastroenterol. 2022;13(4):e00464. doi:10.14309/ctg.0000000000000464
   PubMed Web of Science ®Google Scholar
• Parkin CJ, Bell SW, Mirbagheri N. Colorectal cancer screening in Australia: an update. Aust J Gen Pract. 2018;47(12):859–863. doi:10.31128/AJGP-01-18-4472
   PubMed Web of Science ®Google Scholar